Compare MRVI & MSEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRVI | MSEX |
|---|---|---|
| Founded | 2014 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 984.5M |
| IPO Year | 2020 | 1995 |
| Metric | MRVI | MSEX |
|---|---|---|
| Price | $5.76 | $59.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $4.13 | ★ $61.33 |
| AVG Volume (30 Days) | ★ 2.0M | 116.9K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.77% |
| EPS Growth | ★ 14.29 | N/A |
| EPS | N/A | ★ 1.36 |
| Revenue | $185,743,000.00 | ★ $194,694,000.00 |
| Revenue This Year | $12.54 | $10.60 |
| Revenue Next Year | $7.87 | $10.94 |
| P/E Ratio | ★ N/A | $42.66 |
| Revenue Growth | N/A | ★ 1.47 |
| 52 Week Low | $2.29 | $44.94 |
| 52 Week High | $7.44 | $62.18 |
| Indicator | MRVI | MSEX |
|---|---|---|
| Relative Strength Index (RSI) | 36.84 | 62.13 |
| Support Level | $5.54 | $49.67 |
| Resistance Level | $6.55 | N/A |
| Average True Range (ATR) | 0.31 | 1.38 |
| MACD | -0.12 | 0.04 |
| Stochastic Oscillator | 25.37 | 83.19 |
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.